Planet 13 Holdings (PLNH) Other Non Operating Income (2021 - 2025)
Planet 13 Holdings' (PLNH) quarterly Other Non Operating Income came in at -$224.0 in Q2 2025, up 96.77% year-on-year from -$113.84 in Q2 2024, and up 92.25% on a QoQ basis from -$2889.0 in Q1 2025.
Planet 13 Holdings (PLNH) Other Non Operating Income (2021 - 2025) Analysis & Trends
Planet 13 Holdings (PLNH) has 5 years of Other Non Operating Income data on file, last reported at -$224.0 in Q2 2025.
- On a quarterly basis, Other Non Operating Income rose 96.77% year-over-year to -$224.0 in Q2 2025; TTM through Mar 2026 was -$224.0, a 98.48% increase from a year earlier, with the FY2025 full-year figure at -$3113.0, up 79.17% from the prior year.
- Other Non Operating Income for Q2 2025 stood at -$224.0, up from -$2889.0 in the prior quarter.
- Over the last five years, Other Non Operating Income for PLNH reached as high as $4.4 million in Q4 2021 and fell as low as -$6945.0 in Q2 2024.
- Historically, Other Non Operating Income has averaged $631173.2 across 5 years, with a median of $3058.0 in 2023.
- Across the five-year window, Other Non Operating Income jumped 59950.79% in 2023 and sank 1610.34% in 2024, its largest moves.
- Year by year, Other Non Operating Income stood at $4.4 million in 2021, then plunged by 100.06% to -$2528.0 in 2022, then soared by 59950.79% to $1.5 million in 2023, then tumbled by 100.12% to -$1834.0 in 2024, then soared by 87.79% to -$224.0 in 2025.
- Per Business Quant data, the three most recent Other Non Operating Income figures were -$224.0 in Q2 2025, -$2889.0 in Q1 2025, and -$1834.0 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.46 Bn | 87.60 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.98 Bn | 32.24 Bn | 1.97 Bn |
| 3 | Zoetis | 32.62 Bn | 30.68 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.05 Bn | 20.90 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - |
| 7 | Viatris | 20.27 Bn | 18.47 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.78 Bn | 16.47 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.63 Bn | 12.20 Bn | 785.00 Mn |
| 10 | Planet 13 Holdings | 39.32 Mn | 23.06 Mn | 9.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -224.00 |
| Mar 31, 2025 | -2,889.00 |
| Dec 31, 2024 | -1,834.00 |
| Sep 30, 2024 | -3,066.00 |
| Jun 30, 2024 | -6,945.00 |
| Mar 31, 2024 | -3,097.00 |
| Dec 31, 2023 | 1.51 Mn |
| Sep 30, 2023 | 203.00 |
| Jun 30, 2023 | 4,229.00 |
| Mar 31, 2023 | 1,887.00 |
| Dec 31, 2022 | -2,528.00 |
| Sep 30, 2022 | 197,721.00 |
| Jun 30, 2022 | 74,543.00 |
| Mar 31, 2022 | 4.16 Mn |
| Dec 31, 2021 | 4.39 Mn |
| Sep 30, 2021 | 79,688.00 |
| Jun 30, 2021 | 896,630.00 |
| Mar 31, 2021 | 62,897.00 |